A retrospective study assessing the survival impact among occidental patients with metastatic gastric cancer (mGC) treated with ramucirumab as second line treatment
Latest Information Update: 26 Jul 2021
At a glance
- Drugs Ramucirumab (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- 26 Jul 2021 New trial record
- 08 Jun 2021 Results presented at the 57th Annual Meeting of the American Society of Clinical Oncology